Navigation Links
Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting
Date:4/2/2009

NATIONAL HARBOR, Md, April 2 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM) will present an expert panel of physicians in skin tightening and resurfacing today from 6:00 pm to 8:00 pm at the 29th Annual Meeting of American Society for Lasers in Medicine & Surgery (ASLMS). The roundtable discussion will feature Drs. Brian Biesman, Michael Kaminer, Tina Alster, Amy Taub and Robert Weiss discussing their experiences combining Thermage and Fraxel procedures to deliver effective clinical outcomes for patients.

    The distinguished panel will discuss their experiences with:
      --   Clinical outcomes based on nearly 10,000 Thermage and Fraxel
           procedures performed
      --   Treatment protocols and patient selection of the combined procedure
      --   Marketing and patient education

Beginning on Sunday, April 5, the roundtable will be available via webcast at http://sufo.org/thermage and http://sufo.org/fraxel through a unique partnership with the web-based educational forum.

"By combining the Thermage and Fraxel procedures sequentially, our experience has shown greater tightening and greater smoothing of the skin than with either procedure alone," said Robert Weiss, MD, founder of the Maryland Laser, Skin and Vein Institute. "We sometimes refer to the enhanced effect of both procedures combined as the '1 + 1 = 3' effect, as patients see the benefits of greater tightening from Thermage and greater smoothing from Fraxel than could be achieved by either modality alone." You can download Dr. Weiss's white paper titled: The Sequential Combination of Thermage(R) and Fraxel(R) Treatments Results in Synergistic Improvements at solta.com/aslms.

"Thermage and Fraxel provide proven and trusted results, with minimal downtime and at a fraction of the cost of surgery," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "Physicians who offer both Thermage for skin tightening and Fraxel for skin resurfacing give their business a competitive advantage by providing the two leading treatments patients ask for by name."

According to a recent report from the American Society of Plastic Surgeons (ASPS), demand for minimally-invasive cosmetic procedures grew by 5% to 10.4 million procedures in 2008. The study also found that surgical procedures fell 9% in 2008, the first such decline since 2004(1).

Several physicians presenting at ASLMS will discuss their clinical findings using Thermage and Fraxel systems. A sample of these presentations is listed below.

      --   "Blepharoplasty-Like Results with Periorbital Fractional CO2
           Laser," by Lori Brightman, M.D., Laser & Skin Surgery Center of New
           York, New York, NY, on Friday, April 3, 2009, at 4:31 p.m.
      --   "The Safety and Efficacy of a Second Generation 1550nm Erbium Doped
           Laser in Skin Types IV to VI," by Vic Narurkar, M.D., Bay Area
           Laser Institute, San Francisco, CA, on Saturday, April 4, 2009 at
           4:37 p.m.
      --   "Treatment of Burn Scars with 1550nm Non-Ablative Fractional Erbium
           Laser," by Jill Waibel, M.D., Palm Beach Esthetic Dermatology and
           Laser Center, West Palm Beach, FL, on Saturday, April 4, 2009 at
           5:20 p.m.
      --   "Fractional Photothermolysis for the Treatment of Melasma: A Report
           of Eight Cases with Long-Term Follow-up," by Tracy Katz, M.D.,
           Dermsurgery Associates, Houston, TX, on Sunday, April 5, 2009 at
           8:12 a.m.

ABOUT SOLTA MEDICAL

Solta Medical is a global leader in the medical aesthetics market providing innovative, safe and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians.

The company offers products to address aging skin under the industry's two premier brands: Thermage(R) and Fraxel(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, approximately one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

(1)Source: ASPS 2008 National Plastic Surgery Statistics

                     CONTACT COMPANY           MEDIA RELATIONS
                     MICHAEL HROMADIK          CHRIS LALLI
                     SOLTA MEDICAL, INC.       COHN & WOLFE
                     (510) 780-4694            (415) 365-8540
                     mhromadik@solta.com       Chris.lalli@cohnwolfe.com


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
2. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
3. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
4. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
5. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
6. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
7. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
8. Medical Nurse Training, Inc. Announces the Launch of Medicalnursetraining.com
9. Mayo Clinic and IBM host medical language initiative
10. Providences LogistiCare Subsidiary Receives Notice of Award for Five Year Approximately $300 Million New Jersey Statewide Non-Emergency Medical Transportation Contract
11. Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: